NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/05/2024
Voltar para busca
Dado oficial do USPTO
RESPIRISCINT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
RESPIRISCINT
ST13
US500000097149106Classe
1, 5, 9, 10
Pedido
97149106
Registro
7376907
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
07/05/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
30/11/2021
Data de registro
07/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/05/2024
Última transação
07/05/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
New South Wales, AU
Examinador
HERRERA-MARCUS, ROSELLE MORALDE
Unidade examinadora
N60
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Cyclomedica Australia Pty Ltd
Representantes
Boris Umansky, Esq. LADAS & PARRY LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Precursors for medicineschemical precursors for use in the manufacture of radiopharmaceuticals used in diagnostic imaging in the field of nuclear medicine; precursors for pharmaceuticalschemical precursors for use in the manufacture of nuclear pharmaceuticals used in diagnostic imaging; chemical preparations for use in the pharmaceutical industry in the field of nuclear medicine; chemical products for use in the manufacture of radiopharmaceuticals for scientific purposes; chemical products for use in the manufacture of pharmaceuticals in the nature of radiopharmaceuticals
Classe 5
Chemical preparations and substances for medical purposesdiagnostic purposesmedical sciencemedical analysis purposes and medical imaging purposesgas mixtures for medical imaging use and diagnostic radiopharmaceutical preparations; diagnostic reagents for medical purposes; chemical reagents for medical purposes; pharmaceutical and veterinary preparations for the diagnosis and treatment of pneumological and oncological conditions; pharmaceutical and veterinary gas mixtures for the diagnosis and treatment of pneumological and oncological conditions; radioactive pharmaceutical preparations for medical diagnosis; radioactive pharmaceutical preparations for medical use
Classe 9
Crucibles for laboratory use; heat exchange crucibles for scientific use; scientificresearchweighingmeasuringdetectingtestingapparatus and instrumentsgas simulation apparatus in the nature of environmental test chambers
Classe 10
Surgical and medical apparatus and instruments for use in oncological surgerynuclear medicine diagnostic imaging equipment and crucibles which are component parts of nuclear medicine diagnostic imaging equipment; medical analysis apparatus namely nuclear medicine diagnostic imaging equipment and crucibles which are component parts of nuclear medicine diagnostic imaging equipment; apparatus for medical diagnostic purposes namely nuclear medicine diagnostic imaging equipment and crucibles which are component parts of nuclear medicine diagnostic imaging equipment; medical diagnostic apparatusnuclear medicine diagnostic imaging equipment and crucibles which are component parts of nuclear medicine diagnostic imaging equipment; protective face masks for medical use; radiation shieldingpatient x-ray radiation shields
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
07/05/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
02/04/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/04/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/10/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
03/10/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
29/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/09/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/07/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
25/03/2023
GNSL
LETTER OF SUSPENSION E-MAILED
25/03/2023
CNSL
SUSPENSION LETTER WRITTEN
25/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/09/2022
GNRT
NON-FINAL ACTION E-MAILED
14/09/2022
CNRT
NON-FINAL ACTION WRITTEN
14/09/2022
DOCK
ASSIGNED TO EXAMINER
08/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/03/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
24/03/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
24/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2021
NWAP
NEW APPLICATION ENTERED
03/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RESPIRISCINT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.